Elderly patients with acute myeloid leukemia are often undertreated.
Transplantation outcomes in elderly patients with acute myeloid leukemia are poorly defined.
A meta-analysis shows efficacy of allografting in elderly patients with acute myeloid leukemia and little publication bias.
Thirty-five percent of elderly patients with acute myeloid leukemia are alive and in remission 3 years after transplantation.
Age should not be the sole factor in making treatment decisions in elderly patients with acute myeloid leukemia.